ALCON EYE CARE UK LIMITED
Get an alert when ALCON EYE CARE UK LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-05-10 (in 1y)
Last made up 2026-04-26
Watchouts
None on the register
Cash
£4M
-39.3% vs 2023
Net assets
£53M
+11.6% highest in 4 filed years
Employees
210
-2.3% vs 2023
Profit before tax
£8M
-1.1% vs 2023
Name history
Renamed 2 times since incorporation
- ALCON EYE CARE UK LIMITED 2012-08-01 → present
- CIBAVISION (U.K.) LIMITED 1988-12-22 → 2012-08-01
- CONTACTASOL LIMITED 1964-06-16 → 1988-12-22
Net assets
4-year trend · vs Industrials median
Accounts
4-year trend · latest reflected 2024-12-31
| Metric | Trend | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|
| Turnover | £139,093 | £151,038 | £166,373,000 | £172,168,000 | |
| Operating profit | £3,442 | £9,262 | £8,155,000 | £7,958,000 | |
| Profit before tax | £3,074 | £8,830 | £7,669,000 | £7,588,000 | |
| Net profit | — | — | £4,694,000 | £5,681,000 | |
| Cash | £283 | £12,486 | £6,383,000 | £3,876,000 | |
| Total assets less current liabilities | £63,898 | £61,867 | £62,012,000 | £67,276,000 | |
| Net assets | £45,105 | £43,703 | £47,221,000 | £52,682,000 | |
| Equity | £45,105 | £43,703 | £47,221,000 | £52,682,000 | |
| Average employees | 201 | 211 | 215 | 210 | |
| Wages | — | — | £17,773,000 | £18,409,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|
| Operating margin | 2.5% | 6.1% | 4.9% | 4.6% | |
| Net margin | — | — | 2.8% | 3.3% | |
| Return on capital employed | 5.4% | 15.0% | 13.2% | 11.8% | |
| Current ratio | — | — | 2.82x | 3.25x | |
| Interest cover | 8.29x | 19.34x | 8.75x | 13.09x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements have been prepared on the going concern basis as the Directors have a reasonable expectation that the Company has adequate resources for a period of at least 12 months from the date of the approval of the financial statements and that there are no material uncertainties to disclose.”
Group structure
- ALCON EYE CARE UK LIMITED · parent
- Alcon Laboratories (U.K.) Limited 100%
Significant events
- “Since Brexit became effective in January 2021, Alcon Eye Care UK Limited has been impacted by adverse events, particularly regarding the specific status of Northern Ireland, which increases complexity in logistics, invoicing, and indirect tax. Risk mitigation efforts have focused on ongoing adaptation of systems, processes, and logistic flows, especially when servicing both the Republic of Ireland and Northern Ireland.”
- “Post-Brexit UK medical device regulations may diverge from EU standards/requirements, potentially impacting product approval timelines, distribution efficiency, or cost structures. Risk mitigation has focused on partnering with trade associations and the UK government to ensure EU and global regulatory alignment ahead of future regulations expected in 2026.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 49 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| WESTON, Rebecca | Secretary | 2021-01-21 | — | — |
| HENRY, Roy Lindsay Allen | Director | 2019-04-09 | Aug 1968 | British |
| KOSTETSKAYA, Olga | Director | 2024-04-12 | Sep 1971 | Ukrainian |
| ROMEU, Xavier | Director | 2020-07-06 | Dec 1964 | French |
Show 49 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| HENRY, Roy Lindsay Allen | Secretary | 2017-06-22 | 2018-06-14 |
| HOUSDEN, John Eric, Dr | Secretary | 1995-05-01 | 1997-06-30 |
| JENNINGS, Sally Jane | Secretary | 2001-01-23 | 2008-03-11 |
| KAYA, Sinan | Secretary | 2020-07-06 | 2021-01-21 |
| KHOO, Cheryl Tsu Lynn | Secretary | 2018-06-14 | 2020-05-31 |
| MAXTED, Nicola Karen | Secretary | 2010-06-18 | 2017-06-22 |
| ROBERTS, Helen | Secretary | 2008-03-11 | 2010-06-18 |
| THIRKETTLE, Paul Richard Edward | Secretary | 1997-06-30 | 2001-01-23 |
| TINKER, David Timothy | Secretary | — | 1995-04-29 |
| ADAMS, Adrian | Director | 2001-01-23 | 2001-06-08 |
| AHMAD, Haseeb | Director | 2017-03-08 | 2019-04-09 |
| ARROCHA, Edgar Humberto | Director | 2014-08-26 | 2016-08-15 |
| ASHTON, David Thomas | Director | 2001-01-23 | 2001-09-27 |
| ATTIAS, Laurent | Director | 2012-05-24 | 2013-02-12 |
| BARNES, Howard | Director | 2004-10-14 | 2008-09-30 |
| BARNETT, Terence Anthony | Director | 1996-04-06 | 1997-06-30 |
| BELL, Ian Howard | Director | 2016-04-19 | 2019-04-09 |
| BOURDAGE, Pierre Richard | Director | 2015-12-17 | 2018-06-14 |
| BRAZIER, Richard John | Director | 2006-02-22 | 2009-07-01 |
| CARLEN, Roland | Director | 2004-02-06 | 2005-01-01 |
| COLOMBO, Franco | Director | 2019-04-09 | 2020-07-06 |
| COOK, Chantelle | Director | 2020-07-06 | 2021-10-01 |
| CUMMINS, Gordon John | Director | 2004-05-20 | 2006-02-01 |
| FAHEY, Michael John | Director | 2001-12-04 | 2004-04-20 |
| FRASER, John Stewart | Director | — | 1996-03-31 |
| FULLAGAR, Edgar | Director | 1997-06-30 | 2002-04-23 |
| GOWER ISAAC, Harriet | Director | 2019-04-09 | 2020-07-06 |
| HAMMOND, Daniel | Director | 2004-04-21 | 2004-10-14 |
| HOUSDEN, John Eric, Dr | Director | 1995-05-01 | 1999-04-14 |
| HOUSDEN, John Eric, Dr | Director | 1992-06-28 | 1993-03-04 |
| JOSE, Teresa | Director | 2009-07-01 | 2012-03-06 |
| KAPADIA, Sandipkumar Shantilal | Director | 2012-03-06 | 2014-08-26 |
| KOHOUT, Susanne Maria | Director | 2007-05-22 | 2012-05-24 |
| KORANGY, Shervin Joe | Director | 2014-06-16 | 2015-12-17 |
| KUDELKA, Jurgen | Director | 1998-10-06 | 2004-02-06 |
| LACAZE, Oriane Fanny | Director | 2016-08-15 | 2019-04-09 |
| LOPEZ, Roger | Director | 2008-11-05 | 2014-06-16 |
| O'DOWD, Hugh Michael | Director | 2015-10-15 | 2016-09-16 |
| PARIS, William Drummond | Director | 2001-09-14 | 2005-04-22 |
| RAETZMAN, Stuart Colin | Director | 2013-02-12 | 2014-03-19 |
| SAIA, Andrea Lynn | Director | 2005-01-01 | 2007-05-22 |
| SAXENA, Subhanu | Director | 2005-04-20 | 2009-08-26 |
| SHERIF, Riad | Director | 2014-06-04 | 2016-04-19 |
| STROPPEL, Stefan Hans | Director | 1998-01-19 | 2001-01-23 |
| SWALWELL, Marcus Charles | Director | 1999-04-14 | 2004-04-21 |
| TERRELL, Robin Guy | Director | — | 1998-10-06 |
| TRIMMING, Julian William | Director | — | 1995-02-21 |
| TURNER, Michael Christopher | Director | 2021-10-01 | 2024-02-29 |
| WEBB, Susan Ann | Director | 2009-08-26 | 2015-09-01 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Alcon Inc. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2018-12-12 | Active |
| Novartis Ag | Corporate entity | Shares 50–75%, Voting 50–75%, Appoints directors | 2016-04-06 | Ceased 2018-12-12 |
Filing timeline
Last 20 of 241 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-05-05 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-08-21 | AA | accounts | Accounts with accounts type full | |
| 2025-05-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-08-22 | AA | accounts | Accounts with accounts type full | |
| 2024-04-26 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-04-19 | AP01 | officers | Appoint person director company with name date | |
| 2024-04-18 | TM01 | officers | Termination director company with name termination date | |
| 2023-08-16 | AAMD | accounts | Accounts amended with accounts type full | |
| 2023-06-12 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-06-12 | AA | accounts | Accounts with accounts type total exemption full | |
| 2023-02-17 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-10-05 | AA | accounts | Accounts with accounts type full | |
| 2022-04-19 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-10-26 | TM01 | officers | Termination director company with name termination date | |
| 2021-10-26 | AP01 | officers | Appoint person director company with name date | |
| 2021-09-28 | AA | accounts | Accounts with accounts type full | |
| 2021-08-17 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2021-02-02 | AP03 | officers | Appoint person secretary company with name date | |
| 2021-01-29 | TM02 | officers | Termination secretary company with name termination date | |
| 2020-12-10 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+3.5%
£166,373,000 £172,168,000
highest in 4 filed years
-
Cash
-39.3%
£6,383,000 £3,876,000
-
Net assets
+11.6%
£47,221,000 £52,682,000
highest in 4 filed years
-
Employees
-2.3%
215 210
-
Operating profit
-2.4%
£8,155,000 £7,958,000
-
Profit before tax
-1.1%
£7,669,000 £7,588,000
-
Wages
+3.6%
£17,773,000 £18,409,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers